BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data for selected candidates from its oncology pipeline at the American Association for Cancer Research (“AACR”) Annual Meeting 2024 in San Diego, California, fro...
马萨诸塞州沃特敦,2024年3月5日(环球新闻专线)——Acrivon Therapeutics, Inc.(“Acrivon” 或“Acrivon Therapeutics”)(纳斯达克股票代码:ACRV),一家临床阶段的生物制药公司,利用其专有的基于蛋白质组学的患者反应者识别平台Acrivon Predictive,开发精准肿瘤药物,与预计肿瘤对每种特定药物敏感的患者相匹配 Precisio...
DUBLIN, Ireland, March 05, 2024 (GLOBE NEWSWIRE) --Mural Oncology plc(Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, today announced two upcoming ...
D3S-001, at the 2024 AACR Annual Meeting in San Diego, California. These data underscore D3 Bio's groundbreaking progress in cancer treatment. Furthermore, this marks the inaugural disclosure of Phase I clinical data for
AACR2024 注册费: IN-PERSON MEETING REGISTRATION The following items are included with in-person registration: Admission to all live scientific sessions (admission to the Educational Program sessions on Friday and Saturday, April 5 and 6, requires the separate purchase of an AACR Educational Program ...
AACR2024 注册费: IN-PERSON MEETING REGISTRATION The following items are included with in-person registration: Admission to all live scientific sessions (admission to the Educational Program sessions on Friday and Saturday, April 5 and 6, requires the separate purchase of an AACR Educational Program ...
More Details Prices: 184-1405 US Dollar (Estimated) Early registration date: 03 Jan 2025 Exhibition: Included Organizer: AACR - American Association for Cancer Research Website: Abstract submission deadline: 27 Nov 2024 Promote this Event Organizer Remind Review Article Future Events ...
Proteintech is proud to support researchers by offering 2 x $1000 travel grants to attend the 2024 AACR annual meeting in San Diego, CA. Each grant will cover up to $1,000 of expenses towards registration, airfare, and lodging expenses. Scroll down to meet our past winners! Abstract Submiss...
Currently, 16 potentially registration-enabling clinical trials are being conducted in China and globally, including 13 Phase 3 trials and three pivotal Phase 2 trials. In January 2021, BeiGene and Novartis entered into a collaboration and license agreement granting ...
utilizing its proprietary proteomics-based patient responder identification platform, Acrivon Predictive Precision Proteomics (AP3), today announced the company will be presenting data at the American Association for Cancer Research (AACR) Annual Meeting taking place April 5 – 10, 2024 in San Diego,...